Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Allergic Responses of Bee Venom vs Essential Bee Venom
NCT02364349Phase 1Completed
- Sponsor
- Jaseng Hospital of Korean Medicine
- Start
- Jan 2015
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of essential bee venom (2 arms), sponsored by Jaseng Hospital of Korean Medicine. Primary endpoints: Visual Analog Scale on Pain at 48 hours and Wheal and erythema at 24 hours. Started Jan 2015; status: completed.
02
Drugs
essential bee venom
Beyond the preview
Go deeper on NCT02364349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364349.